177 related articles for article (PubMed ID: 9833598)
1. Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.
Schaber G; Stevens I; Gaertner HJ; Dietz K; Breyer-Pfaff U
Br J Clin Pharmacol; 1998 Nov; 46(5):453-9. PubMed ID: 9833598
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
[TBL] [Abstract][Full Text] [Related]
3. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia.
Guitton C; Kinowski JM; Abbar M; Chabrand P; Bressolle F
J Clin Pharmacol; 1999 Jul; 39(7):721-8. PubMed ID: 10392327
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
Wetzel H; Anghelescu I; Szegedi A; Wiesner J; Weigmann H; Härter S; Hiemke C
J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836
[TBL] [Abstract][Full Text] [Related]
5. Disposition of clozapine and desmethylclozapine in schizophrenic patients.
Lin SK; Chang WH; Chung MC; Lam YW; Jann MW
J Clin Pharmacol; 1994 Apr; 34(4):318-24. PubMed ID: 8006199
[TBL] [Abstract][Full Text] [Related]
6. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia.
Raaska K; Raitasuo V; Neuvonen PJ
Eur J Clin Pharmacol; 2001 Dec; 57(10):705-8. PubMed ID: 11829199
[TBL] [Abstract][Full Text] [Related]
7. Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia.
Islam F; Maciukiewicz M; Freeman N; Huang E; Tiwari A; Mulsant BH; Pollock BG; Remington G; Kennedy JL; Müller DJ; Rajji TK
J Psychopharmacol; 2021 Jan; 35(1):31-39. PubMed ID: 33143542
[TBL] [Abstract][Full Text] [Related]
8. Distribution of clozapine and desmethylclozapine between blood and brain in rats.
Weigmann H; Härtter S; Fischer V; Dahmen N; Hiemke C
Eur Neuropsychopharmacol; 1999 Mar; 9(3):253-6. PubMed ID: 10208296
[TBL] [Abstract][Full Text] [Related]
9. Determination of clozapine, and its metabolites, N-desmethylclozapine and clozapine N-oxide in dog plasma using high-performance liquid chromatography.
Mosier KE; Song J; McKay G; Hubbard JW; Fang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(2):377-82. PubMed ID: 12482480
[TBL] [Abstract][Full Text] [Related]
10. Variability of the in vivo metabolism of clozapine.
Raedler TJ; Hinkelmann K; Wiedemann K
Clin Neuropharmacol; 2008; 31(6):347-52. PubMed ID: 19050412
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophrenia.
Golden G; Honigfeld G
Clin Drug Investig; 2008; 28(4):231-9. PubMed ID: 18345713
[TBL] [Abstract][Full Text] [Related]
13. Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients.
Chang WH; Lin SK; Lane HY; Wei FC; Hu WH; Lam YW; Jann MW
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):723-39. PubMed ID: 9723115
[TBL] [Abstract][Full Text] [Related]
14. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.
Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 2000 Nov; 56(8):585-9. PubMed ID: 11151749
[TBL] [Abstract][Full Text] [Related]
16. Automated on-line dialysis, trace enrichment and high-performance liquid chromatography. Inhibition of interaction with the dialysis membrane and disruption of protein binding in the determination of clozapine in human plasma.
Johansen K; Krogh M; Rasmussen KE
J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):223-31. PubMed ID: 9106047
[TBL] [Abstract][Full Text] [Related]
17. Automated determination of clozapine and major metabolites in serum and urine.
Weigmann H; Bierbrauer J; Härtter S; Hiemke C
Ther Drug Monit; 1997 Aug; 19(4):480-8. PubMed ID: 9263393
[TBL] [Abstract][Full Text] [Related]
18. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine.
Eiermann B; Engel G; Johansson I; Zanger UM; Bertilsson L
Br J Clin Pharmacol; 1997 Nov; 44(5):439-46. PubMed ID: 9384460
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole.
Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 1998 Apr; 54(2):167-70. PubMed ID: 9626923
[TBL] [Abstract][Full Text] [Related]
20. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects.
Disanto AR; Golden G
Clin Drug Investig; 2009; 29(8):539-49. PubMed ID: 19591515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
